My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

Stevanato Group S.p.A. Ordinary Shares (NY:STVN)

19.45 +0.05 (+0.26%)

Delayed Quote Updated: 11:19 AM EDT, Oct 12, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

Headline News about Stevanato Group S.p.A. Ordinary Shares

< Previous 1 2 3 Next >

Stevanato Group Q2 Earnings Call Highlights ↗

August 09, 2026

Stevanato Group (NYSE:STVN) reported second-quarter 2026 revenue growth of 8% as demand for higher-value drug containment and delivery products helped lift profitability, while the company updated its...

Via MarketBeat

Topics Earnings

Stevanato (STVN) Q2 2026 Earnings Call Transcript ↗

August 04, 2026

Revenue grew 8% as high-value solutions surged 16%, driving adjusted EBITDA up 21%.

Via The Motley Fool

Topics Earnings

Stevanato Group Q2 2026 Earnings Call: Complete Transcript ↗

August 04, 2026

Stevanato Group (NYSE:STVN) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call...

Via Benzinga

Topics Earnings

2 Dirt Cheap Healthcare Stocks to Buy With $1,000 Right Now ↗

June 09, 2026

Italian healthcare vials and cartridges maker Stevanato Group and U.S. generic and wholesale pharmaceutical company Cencora are two of the best healthcare buys right now.

Via The Motley Fool

Topics Economy

Earnings Scheduled For November 6, 2025 ↗

November 06, 2025

Via Benzinga

How Is The Market Feeling About Stevanato Group? ↗

August 28, 2025

Via Benzinga

Stevanato (STVN) Q1 2026 Earnings Transcript ↗

May 08, 2026

Stevanato (STVN) Q1 2026 Earnings Transcript

Via The Motley Fool

Topics World Trade

End of an Era: West Pharmaceutical Shares Slide as Longtime CEO Eric Green Announces Retirement

March 11, 2026

Shares of West Pharmaceutical Services (NYSE: WST) tumbled 5.7% on Tuesday following the announcement that Eric Green, the company’s President, Chief Executive Officer, and Chair of the Board, intends...

Via MarketMinute

Topics Economy Retirement

Stevanato (STVN) Q4 2025 Earnings Call Transcript ↗

March 04, 2026

Stevanato (STVN) Q4 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Earnings Scheduled For May 8, 2025 ↗

May 08, 2025

Via Benzinga

What's Next: Stevanato Gr's Earnings Preview ↗

November 04, 2024

Via Benzinga

The Biotech Revolution’s Ultimate ‘Picks and Shovels’ Play: A Deep Dive into West Pharmaceutical Services (WST)

December 23, 2025

As the pharmaceutical industry undergoes its most significant transformation in decades, the spotlight often falls on the blockbuster drugs themselves—the weight-loss miracles and the life-saving...

Via MarketMinute

Topics Economy

Picks and Shovels of the Biotech Revolution: A Deep Dive into West Pharmaceutical Services (WST)

December 23, 2025

Date: December 23, 2025 Introduction In the high-stakes world of biotechnology and pharmaceutical manufacturing, few companies are as indispensable yet as quietly influential as West Pharmaceutical...

Via PredictStreet

Topics Economy Intellectual Property Supply Chain

Stevanato (STVN) Q3 2025 Earnings Call Transcript ↗

November 06, 2025

Stevanato (STVN) Q3 2025 Earnings Call Transcript

Via The Motley Fool

Topics Earnings World Trade

Stevanato Group SPA (NYSE:STVN) Tops Q3 2025 Earnings and Revenue Estimates ↗

November 06, 2025

Stevanato Group (STVN) beat Q3 2025 earnings and revenue estimates, driven by record high-value solutions and strong demand for its syringes.

Via Chartmill

Tesla, Apple, Nvidia And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗

April 07, 2025

Via Benzinga

Guess, Tesla, Nvidia And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

April 04, 2025

Via Benzinga

Earnings Scheduled For March 6, 2025 ↗

March 06, 2025

Via Benzinga

Applied Materials, Informatica, Clearwater Paper And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

February 14, 2025

Via Benzinga

Why Airbnb Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket ↗

February 14, 2025

Via Benzinga

Sangamo Therapeutics, Dave And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

December 31, 2024

Via Benzinga

Walgreens Boots Alliance, Alaska Air And RH Are Among Top Mid-Cap Gainers Last Week (December 9-13): Are The Others In Your Portfolio? ↗

December 15, 2024

These 10 mid-cap stocks performed well last week. Are they in your portfolio? PDCO, NAMS, WBA, NVCR, RH, PTVE, CRK, RNW, ALK, STVN.

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 05, 2024

Via Benzinga

Ambarella, Bill Holdings And Box Are Among Top 7 Mid Cap Gainers Last Week (Aug 25-Aug 31): Are The Others In Your Portfolio? ↗

September 02, 2024

Top performing mid-cap stocks in the last week, including Semtech, Stevanato, Ambarella, Ardent Health, BILL, Box, and Grupo Financiero Galicia.

Via Benzinga

Build-A-Bear Workshop Posts Upbeat Earnings, Joins Affirm, Nutanix, Cooper Companies, Veeva Systems And Other Big Stocks Moving Higher On Thursday ↗

August 29, 2024

Via Benzinga

STVN Stock Earnings: Stevanato Gr Misses EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

STVN stock results show that Stevanato Gr missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.

Via InvestorPlace

Why Duolingo Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

May 09, 2024

Via Benzinga

STVN Stock Earnings: Stevanato Gr Misses EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

STVN stock results show that Stevanato Gr missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

Via InvestorPlace

Italy Based Stevanato Reports Mixed Q1 Earnings, Revises Annual Guidance On Temporary Destocking ↗

May 09, 2024

Stevanato Group reports Q1 earnings of 236.0 million euros, down 1% Y/Y. Sales declined due to vial destocking amid pandemic effects. High-value solutions revenue up to 37% driven by syringe demand....

Via Benzinga

< Previous 1 2 3 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.